Afuco™ Anti-IL9 ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-220) (CAT#: AFC-TAB-220)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IL9.
Specific Inquiry
Custom Production
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.
We require custom production
RNA Expression
Figure 1 RNA cell line category: Cell line enriched (HDLM-2)
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000145839-IL9
(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000145839-IL9
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized (from mouse)
- Type
- ADCC enhanced antibody
- Species Reactivity
- Human
- Applications
- Neut, ELISA, IF, IP, FuncS
- Conjugate
- Unconjugated
- Generic Name
- Enokizumab
- Related Disease
- Asthma
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- IL9; interleukin 9; interleukin-9; homolog of mouse T cell and mast cell growth factor 40; HP40; IL 9; P40; p40 cytokine; p40 T cell and mast cell growth factor; T cell growth factor p40; cytokine P40; T-cell growth factor
- Gene ID
- 3578
- UniProt ID
- P15248
Related Resources
Please refer to Enokizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Enokizumab.
Asthma
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Enokizumab"
DrugMonitor™ Anti-Enokizumab Antibody (VS-1224-YC428)Enokizumab is a humanized IgG1 kappa anti-interleukin-9 mAb is currently in development. The DrugMonitor™ Anti-Enokizumab Antibody (VS-1224-YC428) is an anti-drug antibody (ADA) against Enokizumab. This drug-based antibody is raised in mice immunized with the Enokizumab. The anti-Enokizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Enokizumab in samples.
See other products for "IL9"
Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibodies
Neutralizing Antibodies
Blocking Antibodies
Rabbit Monoclonal Antibodies
IgG Antibodies
ScFv Antibodies
Fab Antibodies
FC Reagents & Kits
ScFv-Fc Chimeras
| CAT | Product Name | Application | Type |
|---|---|---|---|
| TAB-220 | Anti-Human IL9 Recombinant Antibody (TAB-220) | WB, Neut, ELISA, IF, IP, FuncS, FC | IgG1 - kappa |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-220. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: WB, IF, IP, Neut, FuncS, ELISA, FC
Application: Neut, ELISA, IF, IP, FuncS, FC, WB
Application: ELISA
Application: Neut, FC, IHC-Fr, IP, BA
Application: Block, IP, IF, FC
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: Neut, IHC, Activ, FuncS, IF, ELISA
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
